Volume Alert - GERN 3.07 Geron Corp $GERN Hit a high today

New Post Public Reply Private Reply Replies (0) Message Board
leahanne
Volume Alert - GERN 3.07 Geron Corp $GERN Hit a high today of 3.12 Closing the day 10:29 at 3.07 +0.09 +3.02% With a day low of 3.00 and a total volume of 2,474,424.

GERN Recent Posts: http://investorshangout.com/Geron-Corporation-GERN-54220/

GERN Geron Corp Recent Headline News

Today's Review on Biotech Equities - Exelixis, Geron, Tekmira Pharma, Galena Biopharma, and XOMA
PR Newswire - Tue Nov 18, 8:00AM CST
Investor-Edge has initiated coverage on the following equities: Exelixis Inc. (NASDAQ: EXEL), Geron Corporation (NASDAQ: GERN), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), Galena Biopharma Inc. (NASDAQ: GALE), and XOMA Corporation (NASDAQ: XOMA). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Monday, November 17, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 17,647.75, up 0.07% and the NASDAQ Composite closed at 4,671.00, down 0.37%. The S&P 500 finished the session 0.07% higher at 2,041.32. During the trading session, four out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 781.08, up 0.49%, with the index advancing 9.06% in the previous three months. Register for your complimentary reports on these five stocks at:
DRNA: 9.82 (+0.32), GERN: 3.10 (+0.12), TKMR: 16.25 (-0.99), GALE: 1.86 (+0.05), XOMA: 4.10 (+0.12), EXEL: 1.78 (+0.02)

Incyte Building Blockbuster Drug One Disease At A Time
at Investor's Business Daily - Mon Nov 17, 2:58PM CST
Sometimes, drug launches take a while to get off the ground. Incyte's only approved drug, Jakafi, has been on the market three years, but it's really only just getting started. Jakafi, sold in some markets as Jakavi, is approved for a rare...
JNJ: 108.99 (+0.69), GILD: 102.45 (+2.01), GERN: 3.10 (+0.12), MRK: 60.06 (+0.60), AZN: 73.72 (+1.22), PFE: 30.62 (+0.30), INCY: 69.58 (-0.12), BMY: 58.70 (+0.27), CTIC: 2.28 (+0.04), NVS: 95.73 (+1.35)

Most active Nasdaq-traded stocks
AP - Mon Nov 17, 1:22PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at 1 p.m.:
GERN: 3.10 (+0.12), FB: 74.27 (+0.03), DNDN: 0.17 (+0.02), SNSS: 2.20 (-0.11), MSFT: 48.93 (-0.53), AAPL: 114.95 (+0.96), CSCO: 26.69 (+0.22)

Hot Stock: Geron, Shares Gain 8.7% (GERN)
Comtex SmarTrend(R) - Mon Nov 17, 12:00PM CST
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 8.7% to $3.00 on 2.7x average daily volume. Geron has traded 8.7 million shares thus far today, vs. average volume of 3.2 million shares per day. The stock has outperformed the Dow (8.7% to the Dow's -0.1%) and outperformed the S&P 500 (8.7% to the S&P's -0.2%) during today's trading.
GERN: 3.10 (+0.12)

J&J deal stokes Geron
Seeking Alpha - at Seeking Alpha - Mon Nov 17, 9:42AM CST

GERN: 3.10 (+0.12)

Geron (GERN) Stock Surges Following Johnson & Johnson Licensing Deal
at The Street - Mon Nov 17, 9:40AM CST
Shares of Geron (GERN) soared in morning trading Monday after the company announced late last week it had licensed its blood disorder drug imetelstat to Johnson & Johnson JNJ.
GERN: 3.10 (+0.12)

Strength Seen in Geron (GERN): Stock Surges 19.5% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 17, 8:25AM CST
Geron (GERN) was a big mover last session, with shares surging over 19% on the day.
BIIB: 305.44 (+3.02), GERN: 3.10 (+0.12), ILMN: 190.29 (+7.38), AFFX: 9.59 (+0.30)

Nasdaq stocks posting largest volume increases
AP - Fri Nov 14, 5:03PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
NVEE: 11.79 (+0.26), GERN: 3.10 (+0.12), RDI: 11.80 (-0.07), RDIB: 12.00 (-0.04)

Geron Collaborates with J&J for Imetelstat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 14, 5:00PM CST
Geron Corporation (GERN), a clinical-stage biopharmaceutical company, announced that it has entered into an exclusive worldwide license and collaboration agreement with Janssen Biotech, Inc., a unit of Johnson & Johnson (JNJ).
BIIB: 305.44 (+3.02), JNJ: 108.99 (+0.69), GERN: 3.10 (+0.12), AFFX: 9.59 (+0.30)

Geron Set to Possibly Pullback After Yesterday's Rally of 19.48%
Comtex SmarTrend(R) - Fri Nov 14, 4:49PM CST
Geron (NASDAQ:GERN) traded in a range yesterday that spanned from a low of $2.72 to a high of $3.33. Yesterday, the shares gained 19.5%, which took the trading range above the 3-day high of $2.44 on volume of 31.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
GERN: 3.10 (+0.12)

Halliburton and Geron are big market movers
AP - Fri Nov 14, 3:29PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
SINA: 39.00 (-0.68), AMZN: 326.77 (+3.72), JNJ: 108.99 (+0.69), HTZ: 22.51 (+0.24), GERN: 3.10 (+0.12), HAL: 49.20 (-0.03), JWN: 73.10 (-0.17), NOK: 7.98 (+0.31), BHI: 65.10 (-0.13)

Geron to Present at the Stifel Healthcare Conference
Thomson Reuters ONE - Fri Nov 14, 3:15PM CST
MENLO PARK, Calif., November 14, 2014 - Geron Corporation (Nasdaq: GERN) today announced that John Scarlett, M.D., President and Chief Executive Officer, will present an overview of the company at the Stifel 2014 Healthcare Conference in New York. The presentation is scheduled to occur on Wednesday, November 19th at 1:50 p.m. Eastern Time.
GERN: 3.10 (+0.12)

Geron's Short Squeeze Is Here
Vahan Avetisyan - Seeking Alpha - Fri Nov 14, 2:40PM CST
Geron' s 2014 D eal to the Rescue Geron (NASDAQ: GERN ) surprised Thursday after-hours when it announced news that it entered into an exclusive worldwide license and collaboration agreement to develop its blood disorder drug imetelstat with...
JNJ: 108.99 (+0.69), GERN: 3.10 (+0.12)

Stock Market Today: Stocks Mixed as Retail Sales Climb, House OKs Keystone Pipeline
at The Street - Fri Nov 14, 2:36PM CST
U.S. stocks fluctuate on Friday, caught between better-than-expected retail sales and more worries of eurozone deflation.
SINA: 39.00 (-0.68), JNJ: 108.99 (+0.69), HTZ: 22.51 (+0.24), VA: 38.50 (+5.82), GERN: 3.10 (+0.12), JWN: 73.10 (-0.17)

Midday Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 11:46AM CST

ZIOP: 3.66 (+0.01), BSPM: 1.30 (-0.04), BDR: 2.23 (+0.57), ZAZA: 3.22 (-0.14), ACY: 8.43 (-0.17), NBS: 4.98 (-1.80), SYRX: 1.30 (-0.01), IAG: 2.44 (+0.17), THTI: 1.35 (unch), BITA: 93.36 (+3.98), VRTB: 4.75 (-0.23), OPTT: 1.11 (+0.01), INVT: 0.85 (-0.02), GERN: 3.10 (+0.12), VASC: 25.01 (+0.53), LOCM: 1.34 (-0.06), CTHR: 1.68 (-0.15), MOV: 26.53 (+0.25), IFON: 1.21 (-0.07), SVM: 1.54 (+0.07)

Traders Get Bullish on Shares of Geron, Shares Up 28.6% (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 10:07AM CST
Geron (NASDAQ:GERN) is one of today's best performing low-priced stocks, up 28.6% to $2.97 on 5.5x average daily volume. Geron has traded 17.8 million shares thus far today, vs. average volume of 3.2 million shares per day. The stock has outperformed the Dow (28.6% to the Dow's -0.0%) and outperformed the S&P 500 (28.6% to the S&P's 0.1%) during today's trading.
GERN: 3.10 (+0.12)

Premarket Gainers / Losers
Seeking Alpha - at Seeking Alpha - Fri Nov 14, 8:13AM CST

BDR: 2.23 (+0.57), GERN: 3.10 (+0.12), TUBE: 16.48 (-0.22), WYY: 1.42 (-0.02), YOD: 2.10 (+0.08), DGLY: 11.61 (-0.05), PBYI: 223.86 (+12.31), ENLK: 28.28 (-0.11), BHI: 65.10 (-0.13), SVM: 1.54 (+0.07)

Upgrade Alert for Geron (GERN)
Comtex SmarTrend(R) - Fri Nov 14, 7:57AM CST
Geron (NASDAQ:GERN) was upgraded from Neutral to Overweight at Piper Jaffray today. The stock closed yesterday at $2.31 on volume of 2.5 million shares, below average daily volume of 3.2 million. Geron share prices have moved between a 52-week high of $7.79 and a 52-week low of $0.91 and closed yesterday at 154% above that low price at $2.31 per share. Over the past week, the 200-day moving average (MA) has gone down 1.8% while the 50-day MA has declined 0.4%.
GERN: 3.10 (+0.12)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navan’s Travel Survey Sells Friction as a Business Case

Updated Category News Views 154

A forgotten charger can turn a routine trip into a small mutiny. That is the useful little truth sitting underneath Navan’s new survey of 2,000 Americans who travel for leisure or business. The company is poking at the annoyances people carry from the bedroom packing pile to the jet bridge: forgotten items, rushed airport arrivals, pre-flight drinks, chatty strangers,...

Continue Reading
SecureSpace Plants a Fifth Flag in Miami Beach Storage

Updated Category News Views 111

A small box on Alton Road may carry outsized weight Miami Beach does not hand out cheap, easy real estate wins, which is why SecureSpace's opening at 633 Alton Road deserves a closer look than its modest footprint might suggest. The newly rebranded SecureSpace Miami Beach facility has 18,358 square feet of traditional storage and locker space spread across 536 units, plus...

Continue Reading
Docusign Pushes Contract Data Into ChatGPT Sales Tools

Updated Category News Views 187

Contracts are where sales momentum goes to get lost, buried under old PDFs, approval chains, and somebody’s half-finished CRM note. Docusign’s November 17, 2026 launch is a sensible attempt to drag that information into the place sellers may increasingly spend their working day: ChatGPT for Sales. The company’s new plugin lets a sales rep pull agreement intelligence...

Continue Reading
Alpha's Training Bet Reaches Into Aesthetic Care Networks

Updated Category News Views 196

Training is becoming part of the operating machine A certificate course is rarely the headline-grabber in healthcare services, yet this one deserves a closer look. Alpha Aesthetics Partners has launched Practice Aesthetics, a unified clinical education platform tied directly to its expanding network of medical aesthetics practices. This is not a public-market ticker...

Continue Reading
ELEGOO's Formnext Push Tests a Broader 3D Ambition

Updated Category News Views 123

Frankfurt’s show floor is where product promises meet some very unforgiving eyeballs. ELEGOO arrived at Formnext 2026 with more than a refreshed machine or two: it is laying out a wider bet across resin printing, FDM printing, and 3D scanning. That matters because the company is no longer presenting itself as merely a supplier of affordable creator hardware. It wants to...

Continue Reading
AMPERA Joins Berto to Power Future Energy Innovations

Updated Category News Views 172

The Power Play You Didn't See Coming AMPERA and Berto just made a move that could stir up some serious waves in the energy sector. They've inked a business combination deal set to push advanced energy technology to the forefront. With AMPERA's valuation clocking in at roughly $900 million, this partnership aims to bring cutting-edge power solutions from concept to market....

Continue Reading
Kobo and CloudLibrary Make Library Ebooks Much Easier

Updated Category News Views 107

A tiny button can change whether a digital service gets used Borrowing an ebook ought not feel like assembling a radio in a dark garage, yet that is roughly where library reading has landed for plenty of people. OCLC's new CloudLibrary integration with Kobo strips out a particularly annoying step: U.S. and Canadian users can link accounts once, borrow a title, and have it...

Continue Reading
MAXHUB's Canon Office Test Puts Hybrid Work on Trial

Updated Category News Views 68

Thirty-nine devices scattered through a new Hong Kong office may not sound earth-shaking, but this is how workplace technology actually earns its keep: not under trade-show lights, but when somebody is late to a meeting in another time zone and the room has to work anyway. MAXHUB and Canon Hong Kong have launched the first officially delivered Co-Create 100 project...

Continue Reading
STORMER LAT Targets Sewer Crews' Costly Access Delays

Updated Category News Views 65

A buried cleanout can turn a simple sewer inspection into a scheduling circus. That unglamorous headache is exactly where FIBERSCOPE is aiming its new STORMER LAT Lateral Launch Camera System, announced November 17, 2026. This is not some flashy consumer gadget hunting for attention; it is field equipment built around a painfully ordinary municipal problem: crews often...

Continue Reading
VisionX AI Bets on Graphs to Track Crypto Crime Nets

Updated Category News Views 74

Money laundering rarely travels in a straight line, and that is precisely the sore spot VisionX AI is trying to jab. The Singapore-based RegTech company has introduced AEGIS, a proprietary Large Graph Model built around financial-crime networks, alongside TraceX, a blockchain investigation platform meant to turn that network view into usable leads. It is a sensible...

Continue Reading

Top 5 Most Recently Viewed Articles

Rocket Lab USA's Earnings Predictions and Market Insights

Updated Category News Views 157

Earned Expectations from Rocket Lab USA Rocket Lab USA (NASDAQ: RKLB) is gearing up for its quarterly earnings report, anticipated by investors with curiosity and optimism. The forthcoming announcement promises to deliver crucial insights into the company's financial health and growth trajectory. Expected Earnings Snapshot Analysts forecast that Rocket Lab will register...

Continue Reading
Upcoming Q2 Financial Results Announcement from Parkland

Updated Category News Views 108

Exciting News from Parkland Corporation Parkland Corporation, known for its dedication to providing quality fuel and convenience products, is gearing up for its next financial milestone. The company anticipates unveiling its second quarter results for 2025, a pivotal moment for investors and stakeholders alike. Key Announcement Details Scheduled to be disclosed after the...

Continue Reading
FLSmidth Secures Major Flotation Technology Contract for Iron Ore

Updated Category News Views 201

FLSmidth Secures Major Flotation Technology Contract for Iron Ore A leading Indian miner and steel producer has made a significant decision by selecting FLSmidth & Co. A/S to deliver a comprehensive flotation technology package for their state-of-the-art iron ore beneficiation plant. This facility is poised to be among the largest and most efficient of its kind globally,...

Continue Reading
Arthur J. Gallagher & Co. Plans Financial Results Conference

Updated Category News Views 118

Arthur J. Gallagher & Co. Announces Key Earnings Details Arthur J. Gallagher & Co. (NYSE: AJG) is gearing up to share its financial results for the fourth quarter of 2025. The announcement will be made after market closure on Thursday, January 29, 2026. Following this release, interested investors will find a printer-friendly version on the company’s official website,...

Continue Reading
Exelixis Faces Investor Scrutiny Amid Financial Reporting Concerns

Updated Category News Views 234

Exelixis under Investigation by Pomerantz Law Firm Pomerantz LLP, a renowned law firm, has initiated an investigation concerning investors of Exelixis, Inc. (NASDAQ: EXEL). This inquiry focuses on potential securities fraud or other unlawful practices involving the company and its leadership. Insights into Recent Financial Performance Recently, Exelixis reported its...

Continue Reading